{
  "id": 257293,
  "title": "BlossomHill, Latigo cap four-IPO week with combined $496M haul",
  "url": "https://urgent.news/2026/08/07/blossomhill-latigo-cap-four-ipo-week-with-combined-496m-haul",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-07T08:39:12.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/blossomhill-latigo-cap-four-ipo-week-with-combined-496m-haul/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A cancer biotech vying for a piece of AstraZeneca's cancer territory and a pain specialist chasing Vertex's landmark non-opioid drug are capping an IPO-heavy week. BlossomHill Therapeutics and Latigo ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}